| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | |||||||||
13,150 | 82,300 | 50,484 | 18,387 | - | - | - | - | - | - |
Revenues | |||||||||
- | - | - | - | 4,687 | 4,998 | 0 | 0 | 0 | 3,525 |
Cost of revenues | |||||||||
- | - | - | - | 814 | 800 | 0 | 0 | 0 | 2,522 |
Cost of revenues | |||||||||
1,931 | 15,271 | 6,008 | 3,037 | - | - | - | - | - | - |
Gross profit | |||||||||
11,219 | 67,029 | 44,476 | 15,350 | 3,873 | 4,198 | 0 | 0 | 0 | 1,003 |
Research and development expense | |||||||||
1,955 | 2,094 | 1,473 | 570 | 391 | 0 | - | - | - | 287 |
Operating Expenses: | |||||||||
Selling, general and administrative expenses | |||||||||
31,675 | 32,190 | 28,596 | 14,427 | 17,362 | 13,813 | 6,225 | 2,759 | 1,818 | 13,280 |
Transaction costs | |||||||||
- | - | - | - | - | - | 790 | 0 | - | - |
Transaction costs | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Amortization of intangible assets | |||||||||
- | - | - | - | - | - | - | - | - | 341 |
Total operating expenses | |||||||||
33,630 | 34,284 | 30,069 | 14,997 | 17,753 | 13,813 | 7,015 | 2,759 | 1,818 | 13,909 |
Loss from operations | |||||||||
-22,411 | 32,745 | 14,407 | 353 | -13,880 | -9,615 | -7,015 | -2,759 | -1,818 | -12,906 |
Loss from discontinued operations net of tax | |||||||||
- | - | - | - | - | -323 | -479 | 0 | - | - |
Loss on disposal of Converted Organics net of tax | |||||||||
- | - | - | - | - | -1,626 | 0 | 0 | - | - |
Net Loss from discontinued operations | |||||||||
- | - | - | - | - | -1,949 | -479 | 0 | - | - |
Net loss attributable to non-controlling interest | |||||||||
- | - | - | - | - | - | - | - | - | -99 |
Net Income / (Loss) | |||||||||
- | - | - | - | - | -10,479 | -6,072 | 50,985 | - | -47,709 |
Loss from sale of investment | |||||||||
-679 | 0 | 0 | - | - | - | - | - | - | - |
Other expense | |||||||||
23 | 0 | 0 | - | - | - | - | - | - | - |
Other income (expense) | |||||||||
Interest income | |||||||||
- | - | - | - | - | - | - | - | 3,124 | - |
Gain on sale of patents, net of legal costs | |||||||||
- | - | - | - | - | - | - | - | 1,280 | - |
Settlement proceeds for modification of licensing agreement | |||||||||
- | - | - | - | - | - | 0 | 3,116 | 0 | - |
Gain on change in fair value of obligations to issue shares | |||||||||
- | - | - | - | - | - | - | - | - | 123 |
(Loss) gain on change in fair value of derivative liability | |||||||||
- | - | - | - | - | - | - | - | - | 1,382 |
Interest and other expense | |||||||||
411 | 829 | 0 | 0 | - | - | - | - | - | 1,725 |
Other Income / (Expense) | |||||||||
Interest and other income | |||||||||
816 | 319 | 27 | - | - | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||
0 | 3,445 | -2,217 | 0 | 0 | - | - | - | - | - |
Gain on settlements, net of legal costs | |||||||||
- | - | - | - | - | 1,000 | 1,000 | 77,353 | 24,908 | - |
Return on investment | |||||||||
- | - | - | - | 1,271 | 0 | - | - | - | - |
Interest and other income | |||||||||
- | - | - | 0 | 12 | 90 | 153 | 164 | - | - |
Total other income (expense) | |||||||||
-297 | -3,955 | 2,244 | 0 | 1,283 | 1,090 | 1,162 | 80,633 | 29,312 | -212 |
Other income (expense), net | |||||||||
- | - | - | - | - | - | 9 | 0 | 0 | 7 |
Loss before income taxes | |||||||||
-22,708 | 28,790 | 16,651 | 353 | -12,597 | -8,525 | -5,853 | 77,874 | 27,494 | -13,118 |
Provision (benefit) for income taxes | |||||||||
-6,218 | 8,052 | -6,160 | 3 | 5 | 5 | -260 | 26,889 | 3,396 | 0 |
Net income (loss) from continuing operations | |||||||||
- | - | - | - | - | - | - | - | - | -13,118 |
Net loss from discontinued operations, net of taxes | |||||||||
- | - | - | - | - | - | - | - | - | -34,690 |
Net loss | |||||||||
-16,490 | 20,738 | 22,811 | 350 | -12,602 | -8,530 | -5,593 | 50,985 | 24,098 | -47,809 |
Accretion of preferred stock | |||||||||
0 | 925 | 4,882 | 6,789 | 0 | - | - | - | - | - |
Net loss to common stockholder | |||||||||
-16,490 | 19,813 | 17,929 | -6,439 | -12,602 | - | - | - | - | - |
Foreign currency translation adjustment | |||||||||
- | - | - | - | - | - | - | - | - | -1 |
Comprehensive (loss) income | |||||||||
- | - | - | - | - | - | - | - | - | -47,710 |
Comprehensive loss attributable to non-controlling interest | |||||||||
- | - | - | - | - | - | - | - | - | -0 |
Comprehensive (loss) income attributable to Converted Organics, Inc. | |||||||||
- | - | - | - | - | - | - | - | - | -47,710 |
Net Loss per share from continuing operations (in dollars per share) | |||||||||
- | - | - | - | - | -0.38 | -0.26 | 2.48 | - | - |
Net Loss per share from discontinued operations (in dollars per share) | |||||||||
- | - | - | - | - | -0.02 | -0.02 | 0.00 | - | - |
Net loss per share from disposal of Converted Organics (in dollars per share) | |||||||||
- | - | - | - | - | -0.07 | 0.00 | 0.00 | - | - |
Net Loss per share from discontinued operations - basic and diluted (in dollars per share) | |||||||||
- | - | - | - | - | -0.09 | -0.02 | 0.00 | - | - |
Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) | |||||||||
- | - | - | - | - | -0.47 | -0.28 | 2.48 | 1.17 | - |
Net income (loss) per share, basic (in dollars per share | |||||||||
-0.60 | 0.75 | 0.90 | 0.02 | - | - | - | - | - | -1,400.44 |
Net income (loss) per share, diluted (in dollars per share) | |||||||||
-0.60 | 0.73 | 0.87 | 0.02 | - | - | - | - | - | - |
Net income (loss) per share, basic (in dollars per share) | |||||||||
- | - | - | - | -0.56 | - | - | - | - | - |
Net income (loss) per share, diluted (in dollars per share) | |||||||||
- | - | - | - | -0.56 | - | - | - | - | - |
Discontinued operations | |||||||||
- | - | - | - | - | - | - | - | - | -3,703.23 |
Net income (loss) per share applicable to common stockholders, basic (in dollars per share) | |||||||||
-0.60 | 0.72 | 0.71 | -0.28 | -0.56 | - | - | - | - | -5,103.67 |
Net income (loss) per share applicable to common stockholders, diluted (in dollars per share) | |||||||||
-0.60 | 0.70 | 0.68 | -0.28 | -0.56 | - | - | - | - | - |
Weighted-average common shares outstanding, basic (in shares) | |||||||||
27,618 | 27,484 | 25,353 | 22,837 | 22,548 | - | - | - | - | - |
Weighted-average common shares outstanding, diluted (in shares) | |||||||||
27,618 | 28,416 | 26,269 | 22,837 | 22,548 | - | - | - | - | - |
Weighted average common shares outstanding, basis and diluted (in shares) | |||||||||
- | - | - | - | - | 22,403 | 21,601 | 20,590 | 20,590 | - |
Weighted average common shares outstanding, basic and diluted | |||||||||
- | - | - | - | - | - | - | - | - | 9 |